Form 8-K - Current report:
SEC Accession No. 0001653477-25-000005
Filing Date
2025-01-16
Accepted
2025-01-16 06:32:21
Documents
16
Period of Report
2025-01-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K ngvt-20250116.htm   iXBRL 8-K 34843
2 EX-99.1 exhibit99111525.htm EX-99.1 21278
6 COMPANY LOGO image1.jpg GRAPHIC 146914
7 COMPANY LOGO ngvt-20250116_g1.jpg GRAPHIC 146914
  Complete submission text file 0001653477-25-000005.txt   689548

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngvt-20250116.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngvt-20250116_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngvt-20250116_pre.xml EX-101.PRE 12603
19 EXTRACTED XBRL INSTANCE DOCUMENT ngvt-20250116_htm.xml XML 2783
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 25534289
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)